tility of Intra-venous autologous bone marrow derived stem cells infusion in chronic stroke. A Paracrine signaling & h-NMR spectroscopy study

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1. Patients diagnosed with ischemic stroke within 1.5 months to 1 year of index event
•2. Age:18-65 years
•3. MRC of hand and wrist muscles between 1-3.
•4. Brunnstrom stage (3-5)
•5. Subjects/ care givers agreed in writing that they will be participating in clinical research, as viewed from the legal representative (patient).

•1. Active Infection
•2. Immunocompromised state history or laboratory results indicative of any significant cardiac, endocrine, hematologic, hepatic, renal, or other disorders
•3. Neoplastic diseases ; malignancy
•4. Autoimmune disorders
•5. Immune-compromised subjects
•6. Progressive neurological worsening
•7. Contraindication to MRI
•8. Female patients with known pregnancy or at risk of pregnancy, positive urine pregnancy test at screening.
•9. Any other reason that, in the opinion of the Principal Investigator, makes the participant
•unsuitable for participation in the study.

发起方